HTGM News and Press, HTG Molecular Diagnostics Inc. From 09/08/20

Top Biotech Penny Stocks To Watch Biotech penny stocks have evolved since 2020 began. What has mainly driven these stocks is the coronavirus pandemic. The COVID-19 outbreak has caused many hurdles that people did not expect this year. This has caused biotech companies to scramble in search o...

TUCSON, Ariz., Aug. 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commercial release and immediate availability of HTG EdgeSeq Reveal version 3.0, adding additio...

TUCSON, Ariz., Aug. 14, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today provided an update regarding its patent infringement claims against BioSpyder Technologies, Inc (BioSpyder). ...

As of June 30, 2020, HTG Molecular Diagnostics ( HTGM -16.1% ) reported cash and equivalents and short-term available-for-sale securities at $32.9M, with current liabilities of ~$4.9M and non-current liabilities of $15.7M. More news on: HTG Molecular Diagnostics, Inc., Healthcare stock...

HTG Molecular Diagnostics, Inc. (HTGM) Q2 2020 Earnings Conference Call August 11, 2020 4:30 PM ET Company Participants Monique Kosse – LifeSci Advisors John Lubniewski – Chief Executive Officer Shaun McMeans – Chief Financial Officer Conference Call Parti...

HTG Molecular (NASDAQ: HTGM ) : Q2 GAAP EPS of -$0.09 in-line. More news on: HTG Molecular Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

TUCSON, Ariz., Aug. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2020. Recent Accomplishments & Highligh...

HTG Molecular Diagnostics (NASDAQ: HTGM ) has signed a Commercialization and Distribution Agreement with Qiagen Manchester, a wholly owned subsidiary of Qiagen N.V. (NYSE: QGEN ) . More news on: QIAGEN N.V., HTG Molecular Diagnostics, Inc., Healthcare stocks news, Read more ...

What Do Analysts Think About These Penny Stocks To Buy For Less Than $3? As the saying goes with penny stocks : just because they’re low-priced doesn’t mean they’re “cheap”. This is a distinction new traders won’t understand until they find penny sto...

TUCSON, Ariz., Aug. 10, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manche...